Skip to content
DataLookout
Menu

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. clinical trial pipeline

Get alerts when Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: H1710 for Injection · Advanced Solid Tumors Primary completion pushed from Sep 4, 2026 to Jan 31, 2027 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.Phase 1 NCT06992713
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
1
Get alerts when Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free